Novo Integrated Sciences Total Long Term Liabilities 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Novo Integrated Sciences Total Long Term Liabilities 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$18.2B
DaVita (DVA)	$14.4B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.5B
Elanco Animal Health (ELAN)	$5.9B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$4.8B
LifeStance Health (LFST)	$3B
Amedisys (AMED)	$3B
Addus HomeCare (ADUS)	$2.3B
Astrana Health (ASTH)	$2.1B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$909M
Aveanna Healthcare Holdings (AVAH)	$889M
Atai Life Sciences (ATAI)	$260M
Bioqual (BIOQ)	$55M
Daxor (DXR)	$37M
Ontrak (OTRK)	$7M
MEDIROM Healthcare Technologies (MRM)	$5M
IMAC Holdings (BACK)	$1M
Psychemedics (PMD)	$0M